Literature DB >> 19845468

PTEN and TRP53 independently suppress Nanog expression in spermatogonial stem cells.

Ewart W Kuijk1, Alain van Mil, Bas Brinkhof, Louis C Penning, Ben Colenbrander, Bernard A J Roelen.   

Abstract

Mammalian spermatogonial stem cells are a special type of adult stem cells because they can contribute to the next generation. Knockout studies have indicated a role for TRP53 and PTEN in insulating male germ cells from pluripotency, but the mechanism by which this is achieved is largely unknown. To get more insight in these processes, an RNAi experiment was performed on the mouse spermatogonial stem cell line GSDG1. Lipofectaminemediated transfection of siRNAs directed against Trp53 and Pten resulted in decreased expression levels as determined by quantitative RT-PCR and immunoblotting. The effects of knockdown were examined by determining the expression levels of genes that are involved in reprogramming and pluripotency of cells, specifically Nanog, Eras, c-Myc, Klf4, Oct4, and Sox2. Additionally, the effects of TRP53 or PTEN knockdown on Plzf and Ddx4 expression were measured, which are highly expressed in spermatogonial stem cells and differentiating male germ cells, respectively. The main finding of this study is that knockdown of Trp53 and Pten independently resulted in significantly higher expression levels of the pluripotency-associated gene Nanog, and we hypothesize that TRP53 and PTEN mediated repression is important for the insulation of male germ cells from pluripotency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19845468     DOI: 10.1089/scd.2009.0276

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  11 in total

1.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

2.  Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.

Authors:  Inna Lipchina; Yechiel Elkabetz; Markus Hafner; Robert Sheridan; Aleksandra Mihailovic; Thomas Tuschl; Chris Sander; Lorenz Studer; Doron Betel
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

Review 3.  Pluripotency of male germline stem cells.

Authors:  Sungtae Kim; Juan Carlos Izpisua Belmonte
Journal:  Mol Cells       Date:  2011-03-24       Impact factor: 5.034

Review 4.  Cell-intrinsic reprogramming capability: gain or loss of pluripotency in germ cells.

Authors:  Masanori Imamura; Zachary Yu-Ching Lin; Hideyuki Okano
Journal:  Reprod Med Biol       Date:  2012-06-19

5.  Generation of Mouse Spermatogonial Stem-Cell-Colonies in A Non-Adherent Culture.

Authors:  Hossein Azizi; Thomas Skutella; Abdolhossein Shahverdi
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

6.  The synergistic effect of 5Azadc and TSA on maintenance of pluripotency of chicken ESCs by overexpression of NANOG gene.

Authors:  Xiaoyan Wang; Yingjie Wang; Qisheng Zuo; Dong Li; Wenhui Zhang; Chao Lian; Beibei Tang; Tianrong Xiao; Man Wang; Kehua Wang; Bichun Li; Yani Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-01-28       Impact factor: 2.416

7.  miR-34 miRNAs provide a barrier for somatic cell reprogramming.

Authors:  Yong Jin Choi; Chao-Po Lin; Jaclyn J Ho; Xingyue He; Nobuhiro Okada; Pengcheng Bu; Yingchao Zhong; Sang Yong Kim; Margaux J Bennett; Caifu Chen; Arzu Ozturk; Geoffrey G Hicks; Greg J Hannon; Lin He
Journal:  Nat Cell Biol       Date:  2011-10-23       Impact factor: 28.824

Review 8.  Spermatogonial stem cells, infertility and testicular cancer.

Authors:  Shree Ram Singh; Ozanna Burnicka-Turek; Chhavi Chauhan; Steven X Hou
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

9.  PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis.

Authors:  JingPing Cao; Shu Zhu; Wei Zhou; Jie Li; Chang Liu; HanQing Xuan; Jie Yan; Lin Zheng; LiXin Zhou; JianXiu Yu; GuoQiang Chen; YiRan Huang; Zhuo Yu; LiXin Feng
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

Review 10.  PTEN Inhibition in Human Disease Therapy.

Authors:  Rafael Pulido
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.